SK Bioscience Co Ltd (302440) — Cash Flow Reinvestment Rate
SK Bioscience Co Ltd (302440) has a Cash Flow Reinvestment Rate of 4.95x as of September 2025, reinvesting ₩102.27 Billion (capex ₩70.94 Billion plus investments ₩-31.32 Billion) from operating cash flow of ₩20.65 Billion. See SK Bioscience Co Ltd (302440) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
SK Bioscience Co Ltd Cash Flow Reinvestment Rate (2018–2023)
Historical reinvestment intensity for SK Bioscience Co Ltd across 5 annual periods. For the full cash flow conversion analysis, see 302440 cash generation efficiency.
Annual Cash Flow Reinvestment Rate for SK Bioscience Co Ltd (2018–2023)
Year-by-year capital reinvestment analysis for SK Bioscience Co Ltd. See financial flexibility index of SK Bioscience Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.26x | ₩95.57 Billion | ₩29.35 Billion | ₩50.30 Billion | ▲ +22.4% |
| 2021 | 2.66x | ₩1.43 Trillion | ₩536.59 Billion | ₩42.91 Billion | ▲ +184.7% |
| 2020 | 0.93x | ₩112.32 Billion | ₩120.22 Billion | ₩9.93 Billion | ▼ -45.0% |
| 2019 | 1.70x | ₩37.06 Billion | ₩21.82 Billion | ₩23.97 Billion | ▲ +5.7% |
| 2018 | 1.61x | ₩23.95 Billion | ₩14.90 Billion | ₩6.31 Billion | — |